Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis, and proliferation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 24, Issue 5, 2001, Pages 467-472

  Evans, Sydney M ^a,b   Hahn, Stephan M ^a   Magarelli, Deirdre P ^a   Koch, Cameron J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

EF5; Heterogeneity; Human tumors; Hypoxia; Necrosis; Proliferation; Tumor; Vasculature

Indexed keywords

2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; CD31 ANTIGEN; KI 67 ANTIGEN;

ARTICLE; CELL DEATH; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PHASE 1 CLINICAL TRIAL; TUMOR;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CELL HYPOXIA; CLINICAL TRIALS, PHASE I; ETANIDAZOLE; HUMANS; HYDROCARBONS, FLUORINATED; IMMUNOHISTOCHEMISTRY; INDICATORS AND REAGENTS; NECROSIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0034798178     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200110000-00011     Document Type: Article

References (41)

1. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
2. Oxygenation predicts radiation response and survival in patients with cervix cancer
3. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
4. Intratumoral oxygen tension in metastatic melanoma
5. Direct measurement of the PO2 distribution in human malignant brain tumours
6. Oxygenation status of breast cancer: The Mainz experience
7. Hypoxic regions exist in human prostate carcinoma
8. Detection of hypoxia in human squamous cell carcinoma by EF5 binding
9. Hypoxia in human intraperitonealextremity sarcomas
10. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker
11. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
12. Pharmacokinetics of the 2-nitroimidazole EF5 ([2-(2-nitro-l-H-imidazole-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide] in human patients: Implications for hypoxia measurements in vivo
13. Vascular endothelial growth factor in brains with periventricular leukomalacia
14. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol- 1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]
15. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors
16. Interlaboratory variation in oxygen tension measurement by Eppendorf "histograph" and comparison with hypoxic marker
17. Hypoxia and necrosis in rat 9L glioma and Morris 7777 hepatoma tumors: Comparative measurements using EF5 binding and the Eppendorf needle electrode
18. Hypoxia marker labeling in tumor biopsies: Quantification of labeling variation and criteria for biopsy sectioning
19. Cell and environment interactions in tumor microregions: The multicell spheroid model
20. Vascularization of the continuous human colonic cancer cell line LS 174 T deposited subcutaneously in nude rats
21. Oxygenation of mammary tumors as evaluated by ultrasound-guided computerized-pO2-histography
22. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
23. Oxygenation of head and neck tumors
24. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: Analysis of drug adducts by fluorescent antibodies vs bound radioactivity
25. Oxygenation of human tumors: Evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements
26. The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised pO2 histography
27. Tumor oxygenation correlates with molecular growth determinants in breast cancer
28. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization
29. Changes in oxygenation during radiotherapy in carcinoma of the cervix
30. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
31. Tumor oxygenation a new predictive parameter in locally advanced cancer of the uterine cervix
32. Oxygenation of carcinomas of the uterine cervix: Evaluation by computerized O2 tension measurements
33. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer
34. Oxygenation of human tumors; The Aarhus experience
35. Tumour oxygenation assessed by polarographic needle electrodes and bioenergetic status measured by 31P magnetic resonance spectroscopy in human soft tissue tumours
36. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas
37. Pretreatment oxygenation profiles of human soft tissue sarcomas
38. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography
39. The histological structure of some human lung cancers and the possible implications for radiotherapy
40. Cell selection from a murine tumout using the fluorescent probe Hoechst 33342
41. Concepts of oxygen transport at the microcirculatory level